Physician Access – Specialist Edition

An Insight Syndication Report

 
What motivates specialists to see pharmaceutical sales representatives or medical scientific liaisons and what companies can do to make the most impact from these visits?

The MD Analytics’ Physician Access – Specialist Edition study digs deep to uncover competitive strategies and tactics that specialists best respond to and their rationale for accepting or declining visits. Learn how your organization can achieve optimal access to specialists amidst declining availability and increased competition.

Further your understanding of key motivators and adjust to alternate ways to access specialists based on changing preferences. Discover new avenues of access that are becoming more acceptable and appealing.

Choose the specialty or specialties you are interested in and contact us today to get a jump on the competition.

Key Study Objectives:

• Determine the criteria specialists use to decide whom to see, for how long, at what location and how frequently
• Understand the constraints specialists apply to the number of reps seen per week and the length of calls
• Assess the relative value of communication tools employed in sales calls including: visual aids, samples provided, web and patient information resources, etc…
• Evaluate pharmaceutical companies according to key factors impacting access.
• Gauge specialists’ level of differentiation and relative impact on access among Medical Scientific Liaisons and traditional pharmaceutical sales representatives.

 
Additional Study Details

• Sample Size: open to all medical specialties. A minimum of 30 specialists per client specified specialty
• Final Deliverable: PowerPoint presentation with executive summary of key findings
• Anticipated Field Schedule: contact us for more details
• Optional Extras: Top up sample sizes, recruit from target lists, purchase one or more specialties

 
Opportunities may still exist to include proprietary custom questions. If you are interested in learning more, please contact us before the study goes to field.